Company Filing History:
Years Active: 1988-1998
Title: Celebrating the Innovations of Helen Jensen Schultz
Introduction
Helen Jensen Schultz is a notable inventor based in Falcon Heights, Minnesota, whose work has significantly contributed to the field of pharmaceuticals. With three patents to her name, she has focused on developing topical formulations and transdermal delivery systems that hold potential for treating viral infections. Her contributions reflect a commitment to advancing medical therapies through innovative solutions.
Latest Patents
Helen's latest patents revolve around advanced pharmaceutical formulations and adhesive-coated sheet materials intended for the topical and transdermal delivery of the compound 1-isobutyl-1H-imidazo[4,5-c]-quinolin-4-amine. These include a variety of formulations such as creams and ointments, as well as pressure-sensitive adhesive compositions. The pharmacological methods outlined in her patents propose novel approaches to utilizing these formulations in combating viral infections, showcasing her inventive spirit and dedication to improving patient care.
Career Highlights
Helen is currently associated with Riker Laboratories Inc., where she works tirelessly to innovate within the field of pharmaceutical delivery systems. Her career is marked by a strong focus on research and development, aiming to enhance the efficacy of treatments for various health conditions.
Collaborations
Throughout her career, Helen has collaborated with talented professionals like Steven M. Wick and Gregory R. Nelson. These partnerships have fostered a dynamic exchange of ideas, contributing to the successful development of her patented technologies and reinforcing the collaborative spirit that is vital in scientific advancements.
Conclusion
Helen Jensen Schultz exemplifies the impact of innovation in the pharmaceutical industry. Her patents not only highlight her creativity and technical expertise but also underscore the importance of developing effective therapies for viral infections. As she continues her work at Riker Laboratories Inc., her contributions remain crucial in the ongoing quest for innovative medical solutions.